US EditionPublished • loading... • Updated
Expert Commentary on the Clinical and Surgical Implications of VPI in NSCLC
Summary by ILCN.org (ILCN/WCLC)
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Expert Commentary on the Clinical and Surgical Implications of VPI in NSCLC
A secondary analysis of the randomized clinical trial Cancer and Leukemia Group B (CALGB) 140503 investigated oncologic outcomes in patients with non-small cell lung cancer (NSCLC) who had visceral pleural invasion (VPI) following lobar or sublobar resection.1 Ramón Rami-Porta, MD, PhD, Clinical Chief of the Department of Thoracic Surgery at Hospital Universitari Mútua Terrassa, in Terrassa, Barcelona, Spain, provides expert insight and a surgic…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
